M2i - Molecular Imaging Institute Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

  • Investments
  • 1

M2i - Molecular Imaging Institute General Information

Description

Manufacturer of radiopharmaceutical products intended for use in Positron Emission Tomography (PET) imaging. The company offers a range of licensed imaging agents including FDG, enabling imaging centers across all geographical regions of Ireland to administer patient scans in accordance with standard protocols.

Contact Information

Website
www.m2i.ie
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Blackrock Clinic
  • Dublin
  • Ireland
+353 (01)
Primary Industry
Diagnostic Equipment
Acquirer
Vertical(s)
Corporate Office
  • Blackrock Clinic
  • Dublin
  • Ireland
+353 (01)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

M2i - Molecular Imaging Institute Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore M2i - Molecular Imaging Institute‘s full profile, request access.

Request a free trial

M2i - Molecular Imaging Institute Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

M2i - Molecular Imaging Institute Investments (1)

M2i - Molecular Imaging Institute’s most recent deal was a Joint Venture with Alliance Medical Radiopharmacy. The deal was made on 07-Oct-2002.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Alliance Medical Radiopharmacy 07-Oct-2002 Joint Venture Pharmaceuticals
To view M2i - Molecular Imaging Institute’s complete investments history, request access »

M2i - Molecular Imaging Institute Exits (1)

M2i - Molecular Imaging Institute’s most recent exit was on 07-Oct-2002 from Alliance Medical Radiopharmacy. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Alliance Medical Radiopharmacy 07-Oct-2002 Completed
  • 2 buyers
To view M2i - Molecular Imaging Institute’s complete exits history, request access »

M2i - Molecular Imaging Institute FAQs

  • When was M2i - Molecular Imaging Institute founded?

    M2i - Molecular Imaging Institute was founded in 2001.

  • Where is M2i - Molecular Imaging Institute headquartered?

    M2i - Molecular Imaging Institute is headquartered in Dublin, Ireland.

  • What is the size of M2i - Molecular Imaging Institute?

    M2i - Molecular Imaging Institute has 18 total employees.

  • What industry is M2i - Molecular Imaging Institute in?

    M2i - Molecular Imaging Institute’s primary industry is Diagnostic Equipment.

  • Is M2i - Molecular Imaging Institute a private or public company?

    M2i - Molecular Imaging Institute is a Private company.

  • What is M2i - Molecular Imaging Institute’s current revenue?

    The current revenue for M2i - Molecular Imaging Institute is .

  • When was M2i - Molecular Imaging Institute acquired?

    M2i - Molecular Imaging Institute was acquired on 01-Jan-2021.

  • Who acquired M2i - Molecular Imaging Institute?

    M2i - Molecular Imaging Institute was acquired by Curium Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process